ABSK061
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for ABSK061, covering 2024-08-12 to 2025-12-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With Achondroplasia [Phase 1, Phase 2]